✦ LIBER ✦

O-51 Phase III study (TAX 326) of docetaxel-cisplatin (DC) and docetaxel-carboplatin (DCB) versus vinorelbine-cisplatin (VC) for the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC): analyses in elderly patients

✍ Scribed by Belani, Chandra P.; Fossella, Frank V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-452 Phase III study of docetaxel-cispl

✍ Belani, C.; von Pawel, J.; Pluzanska, A.; Gorbounova, V.; Kaukel, E.; Mattson, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A multicenter, randomized phase III stud

✍ Belani, C.P; Rodriguez, J; von Pawel, J; Pluzanska, A; Gorbounova, V; Millward, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Docetaxel + Cisplatin (DC) and Docetaxel

✍ F. Fossella 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

776 An economic analysis of the TAX 326

✍ N. Leighl; F.A. Shepherd; W.S. Tsao; P. Lindgren; C.B. Belani; F.V. Fossella; P. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Elderly subgroup analysis of a randomize

✍ Chandra P. Belani; Frank Fossella 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

P.40 Oral vinorelbine and gemcitabine (o

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Agelidou, A.; Kotsakis, A.; Kakolyri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB